Program overview
Context
Indication: Glioblastoma
Mechanism: Unknown
Modality: Unknown
Sponsor: Maastricht Radiation Oncology
Chloroquine is flagged as registry stop signal because public records show a registry stop signal, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Glioblastoma
Mechanism: Unknown
Modality: Unknown
Sponsor: Maastricht Radiation Oncology
Registry: 5/5
Timeline: 1/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 4/5
https://clinicaltrials.gov/study/NCT02432417
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02432417 | Registry Stop Signal (WITHDRAWN) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |